170 related articles for article (PubMed ID: 3031072)
1. A study of the mechanism of glucagon-induced protein phosphorylation in isolated rat hepatocytes using (Sp)-cAMPS and (Rp)-cAMPS, the stimulatory and inhibitory diastereomers of adenosine cyclic 3',5'-phosphorothioate.
Connelly PA; Botelho LH; Sisk RB; Garrison JC
J Biol Chem; 1987 Mar; 262(9):4324-32. PubMed ID: 3031072
[TBL] [Abstract][Full Text] [Related]
2. Effects of the specific cAMP antagonist, (Rp)-adenosine cyclic 3',5'-phosphorothioate, on the cAMP-dependent protein kinase-induced activity of hepatic glycogen phosphorylase and glycogen synthase.
Rothermel JD; Perillo NL; Marks JS; Botelho LH
J Biol Chem; 1984 Dec; 259(24):15294-300. PubMed ID: 6096366
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hepatic gluconeogenesis by the Rp-diastereomer of adenosine cyclic 3',5'-phosphorothioate.
Dragland-Meserve CJ; Olivieri MC; Botelho LH
Biochem J; 1986 Jul; 237(2):463-8. PubMed ID: 3026318
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cyclic AMP-dependent protein kinase-induced changes in the kinetic properties of hepatic pyruvate kinase by the specific cyclic AMP antagonist, the (Rp)-diastereomer of adenosine cyclic 3',5'-phosphorothioate.
Dragland-Meserve CJ; Rothermel JD; Houlihan MJ; Botelho LH
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):371-82. PubMed ID: 2993387
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of glycogenolysis in isolated rat hepatocytes by the Rp diastereomer of adenosine cyclic 3',5'-phosphorothioate.
Rothermel JD; Stec WJ; Baraniak J; Jastorff B; Botelho LH
J Biol Chem; 1983 Oct; 258(20):12125-8. PubMed ID: 6313639
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of glucagon-induced glycogenolysis in isolated rat hepatocytes by the Rp diastereomer of adenosine cyclic 3',5'-phosphorothioate.
Rothermel JD; Jastorff B; Botelho LH
J Biol Chem; 1984 Jul; 259(13):8151-5. PubMed ID: 6330102
[TBL] [Abstract][Full Text] [Related]
7. Synergistic inhibition of glucagon-induced effects on hepatic glucose metabolism in the presence of insulin and a cAMP antagonist.
Marks JS; Botelho LH
J Biol Chem; 1986 Dec; 261(34):15895-9. PubMed ID: 3023331
[TBL] [Abstract][Full Text] [Related]
8. Synergistic inhibition of hepatic glycogenolysis in the presence of insulin and a cAMP antagonist.
Marks JS; Botelho LH
J Biol Chem; 1986 Feb; 261(6):2781-5. PubMed ID: 3005264
[TBL] [Abstract][Full Text] [Related]
9. Blockade of granulosa cell differentiation by an antagonistic analog of adenosine 3',5'-cyclic monophosphate (cAMP): central but non-exclusive intermediary role of cAMP in follicle-stimulating hormone action.
Adashi EY; Resnick CE; Jastorff B
Mol Cell Endocrinol; 1990 Jul; 72(1):1-11. PubMed ID: 2177013
[TBL] [Abstract][Full Text] [Related]
10. Hormonal control of fructose 2,6-bisphosphate concentration in isolated rat hepatocytes.
Bartrons R; Hue L; Van Schaftingen E; Hers HG
Biochem J; 1983 Sep; 214(3):829-37. PubMed ID: 6312964
[TBL] [Abstract][Full Text] [Related]
11. Glucose-stimulated insulin secretion is not dependent on activation of protein kinase A.
Persaud SJ; Jones PM; Howell SL
Biochem Biophys Res Commun; 1990 Dec; 173(3):833-9. PubMed ID: 2176491
[TBL] [Abstract][Full Text] [Related]
12. Effects of synthetic cyclic AMP analogs on amylase exocytosis from rat pancreatic acini.
Schäfer C; Steffen H; Printz H; Göke B
Can J Physiol Pharmacol; 1994 Oct; 72(10):1138-47. PubMed ID: 7533648
[TBL] [Abstract][Full Text] [Related]
13. Identifying the molecular switches that determine whether (Rp)-cAMPS functions as an antagonist or an agonist in the activation of cAMP-dependent protein kinase I.
Dostmann WR; Taylor SS
Biochemistry; 1991 Sep; 30(35):8710-6. PubMed ID: 1653606
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of choriogonadotropin-activated steroidogenesis in cultured Leydig tumor cells by the Rp diastereoisomer of adenosine 3',5'-cyclic phosphorothioate.
Pereira ME; Segaloff DL; Ascoli M; Eckstein F
J Biol Chem; 1987 May; 262(13):6093-100. PubMed ID: 2437113
[TBL] [Abstract][Full Text] [Related]
15. Studies on the hepatic calcium-mobilizing activity of aluminum fluoride and glucagon. Modulation by cAMP and phorbol myristate acetate.
Blackmore PF; Exton JH
J Biol Chem; 1986 Aug; 261(24):11056-63. PubMed ID: 2426266
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the activation of the multifunctional Ca2+/calmodulin-dependent protein kinase in response to hormones that increase intracellular Ca2+.
Connelly PA; Sisk RB; Schulman H; Garrison JC
J Biol Chem; 1987 Jul; 262(21):10154-63. PubMed ID: 3611057
[TBL] [Abstract][Full Text] [Related]
17. Regulation by glucagon of hepatic pyruvate kinase, 6-phosphofructo 1-kinase, and fructose-1,6-bisphosphatase.
Pilkis SJ; El-Maghrabi MR; McGrane M; Pilkis J; Claus TH
Fed Proc; 1982 Aug; 41(10):2623-8. PubMed ID: 6286362
[TBL] [Abstract][Full Text] [Related]
18. Rp diastereomeric analogs of cAMP inhibit both cAMP- and cGMP-induced dilation of hamster mesenteric small arteries.
Jackson WF
Pharmacology; 1996 Apr; 52(4):226-34. PubMed ID: 8841085
[TBL] [Abstract][Full Text] [Related]
19. Modulation of cyclic AMP action in the dog thyroid by its agonist and antagonist Sp- and Rp-adenosine 3',5'-monophosphorothioate.
Erneux C; Van Sande J; Jastorff B; Dumont JE
Biochem J; 1986 Feb; 234(1):193-7. PubMed ID: 3010952
[TBL] [Abstract][Full Text] [Related]
20. Insulin activates 6-phosphofructo-2-kinase and pyruvate kinase in the liver. Indirect evidence for an action via a phosphatase.
Assimacopoulos-Jeannet F; Jeanrenaud B
J Biol Chem; 1990 May; 265(13):7202-6. PubMed ID: 2158992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
